Brief: Xilio Therapeutics Appoints Akintunde Bello, Ph.D., To Its Board Of Directors
Xilio Therapeutics Inc XLO.O: XILIO THERAPEUTICS APPOINTS AKINTUNDE BELLO, PH.D., TO ITS BOARD OF DIRECTORS Source text: ID:nGNX1Xwqts Further company coverage: XLO.O
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla